Patent · US Active

Methods for manufacturing adoptive cell therapies

US12291722B2 · kind B2 · utility

0Cited by
45References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 24, 2015
Grant dateMay 6, 2025
Priority date
Expiry dateApr 24, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2810/855
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides compositions and methods for manufacturing adoptive cell therapies. In particular embodiments, the invention provides methods of harvesting populations of cells, isolating and activating PBMCs, expanding T cells, and administering the T cell therapeutic to a subject in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.